Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Olanow

Showing results (11-20 of 160) with videos related to

Pageof 16
Sort By:
Neurology|December 1, 1996
Selegiline: current perspectives on issues related to neuroprotection and mortalityC W Olanow
Journal of Neural Transmission. General Section|January 1, 1993
A scientific rationale for protective therapy in Parkinson's diseaseC W Olanow
JAMA|March 6, 1996
A 61-year-old man with Parkinson's diseaseC W Olanow
Clinical Neurosurgery|January 1, 1981
Current concepts in the management of movement disordersC W Olanow
Annals of Neurology|January 1, 1992
An introduction to the free radical hypothesis in Parkinson's diseaseC W Olanow
Neurologic Clinics|May 1, 1992
Magnetic resonance imaging in parkinsonismC W Olanow
Neurology|July 1, 1997
Attempts to obtain neuroprotection in Parkinson's diseaseC W Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1993
A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's diseaseC W Olanow
Annals of Neurology|September 1, 1996
GPi pallidotomy--have we made a dent in Parkinson's disease?C W Olanow
European Journal of Neurology|October 29, 2000
Why delaying levodopa is a good treatment strategy in early Parkinson's diseaseC W Olanow, F Stocchi
Pageof 16

Showing results (11-20 of 160) with videos related to

Sort By:
Pageof 16
Neurology|December 1, 1996
Selegiline: current perspectives on issues related to neuroprotection and mortalityC W Olanow
Journal of Neural Transmission. General Section|January 1, 1993
A scientific rationale for protective therapy in Parkinson's diseaseC W Olanow
JAMA|March 6, 1996
A 61-year-old man with Parkinson's diseaseC W Olanow
Clinical Neurosurgery|January 1, 1981
Current concepts in the management of movement disordersC W Olanow
Annals of Neurology|January 1, 1992
An introduction to the free radical hypothesis in Parkinson's diseaseC W Olanow
Neurologic Clinics|May 1, 1992
Magnetic resonance imaging in parkinsonismC W Olanow
Neurology|July 1, 1997
Attempts to obtain neuroprotection in Parkinson's diseaseC W Olanow
Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1993
A rationale for monoamine oxidase inhibition as neuroprotective therapy for Parkinson's diseaseC W Olanow
Annals of Neurology|September 1, 1996
GPi pallidotomy--have we made a dent in Parkinson's disease?C W Olanow
European Journal of Neurology|October 29, 2000
Why delaying levodopa is a good treatment strategy in early Parkinson's diseaseC W Olanow, F Stocchi
Pageof 16